This HTML5 document contains 19 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Subject Item

n2:id

marcrel:aut

n4:id n5:id n7:id n9:id n10:id n11:id n12:id n13:id n14:id n15:id n16:id n17:id n18:id n19:id n20:id

dcterms:bibliographicCitation

Devauchelle-Pensec Valérie, Mariette Xavier, Jousse-Joulin Sandrine, Berthelot Jean-Marie, Perdriger Aleth, Hachulla Eric, Puechal Xavier, Le Guern Veronique, Sibilia Jean, Gottenberg Jacques-Eric, Chiche Laurent, Goëb Vincent, Hayem Gilles, Morel Jacques, Zarnitsky Charles, Dubost Jj, Pers Jacques-Olivier, Nowak Emmanuel, Saraux Alain. Tolerance and efficacy of rituximab in primary Sjögren syndrome (TEARS): results of the randomized controlled trial.. Congrès de l'EULAR,"The European League against Rheumatism Congress", Jun 2012, Berlin, Germany. pp.75 Devauchelle-PensecValérie, MarietteXavier, Jousse-JoulinSandrine, BerthelotJean-Marie, PerdrigerAleth, HachullaEric, PuechalXavier, Le GuernVeronique, SibiliaJean, GottenbergJacques-Eric, ChicheLaurent, GoëbVincent, HayemGilles, MorelJacques, ZarnitskyCharles, DubostJj, PersJacques-Olivier, NowakEmmanuel, SarauxAlain . Tolerance and efficacy of rituximab in primary Sjögren syndrome (TEARS): results of the randomized controlled trial. . Congrès de l'EULAR,"The European League against Rheumatism Congress", Jun 2012, Berlin, Germany . pp.75

dcterms:title

Tolerance and efficacy of rituximab in primary Sjögren syndrome (TEARS): results of the randomized controlled trial.

dc:date

2012